Latest Breaking News On - மூளை மருத்துவ - Page 1 : comparemela.com
B Braun Launches CARESAFE™ IV Administration Sets With Optional AirStop
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Disposable Syringes Market Size Worth Around US$ 11 56 Bn
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
B Braun Announces Jennifer Prioleau as New Chief Legal Officer and Chief Compliance Officer
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The global disposable syringes market size is expected to reach USD 12.13 Billion in 2028, and register a CAGR of 5.3% during the forecast period.
Increasing prevalence of various chronic diseases, increasing use of botox injections, and high adoption of injectable drugs are key factors driving market revenue growth.
High preference for administering injectable formulations among doctors in case of emergency or for quicker recovery of patients.
Market growth can be attributed to major factors such as growing geriatric population, preference for injections over drugs over faster recovery, development of technologically advanced syringes, and need for vaccination and immunization programs globally.
Share this article
BETHLEHEM, Pa., April 29, 2021 /PRNewswire/
B. Braun Medical Inc. (B. Braun), a leader in infusion therapy and pain management, today unveiled Peripheral Advantage
®, a new program that is designed to improve patients experience with peripheral intravenous (IV) therapy. The comprehensive program combines clinical instruction, data-driven insights and advanced tools to empower nurses to achieve first-stick success and help prevent many of the complications associated with peripheral IV therapy.
Peripheral Advantage, which is now available to all hospitals nationwide, addresses a long tolerated, yet unacceptable reality: Although vascular access is the most common invasive procedure, most nurses are not provided with the training, techniques or tools they need to achieve first-stick success. Only 57% or less of nursing students receive any form of Peripheral Intravenous Catheter (PIVC) training.